We are live on ! Find out more
NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
+22.81%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
10 Year Est. Return
AUM
$626M
AUM Growth
+$10.4M
Cap. Flow
-$107M
Cap. Flow %
-17.14%
Top 10 Hldgs %
69.81%
Holding
50
New
1
Increased
5
Reduced
12
Closed
11

Sector Composition

1 Communication Services 32.8%
2 Consumer Discretionary 28.25%
3 Financials 12.43%
4 Healthcare 9.71%
5 Technology 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$167B
$5.65M 0.9%
86,959
TAL icon
27
TAL Education Group
TAL
$5.68B
$5.22M 0.83%
144,791
-84,000
-37% -$2.72M
IBB icon
28
iShares Biotechnology ETF
IBB
$9.23B
$4.83M 0.77%
43,200
DB icon
29
Deutsche Bank
DB
$67.3B
$4.33M 0.69%
533,225
SAGE
30
DELISTED
Sage Therapeutics
SAGE
$3.07M 0.49%
19,313
-13,193
-41% -$1.91M
BKNG icon
31
Booking.com
BKNG
$141B
$3.07M 0.49%
+44,000
New +$3.14M
VTRS icon
32
Viatris
VTRS
$20.1B
$2.83M 0.45%
100,000
INCY icon
33
Incyte
INCY
$23.4B
$2.67M 0.43%
31,000
SLB icon
34
SLB Ltd
SLB
$70.3B
$2.42M 0.39%
55,500
MNK
35
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.22M 0.35%
102,000
IOVA icon
36
Iovance Biotherapeutics
IOVA
$2.23B
$2.17M 0.35%
228,442
VKTX icon
37
Viking Therapeutics
VKTX
$4.31B
$1.39M 0.22%
140,000
FLNT
38
Fluent
FLNT
$111M
$1.09M 0.18%
32,467
ARAV
39
DELISTED
Aravive, Inc. Common Stock
ARAV
$287K 0.05%
40,816
APLS
40
DELISTED
Apellis Pharmaceuticals
APLS
-357,142
Closed -$4.71M
CRM icon
41
Salesforce
CRM
$140B
-28,088
Closed -$3.85M
GS icon
42
Goldman Sachs
GS
$314B
-3,700
Closed -$618K
HIMX
43
Himax Technologies
HIMX
$2.23B
-470,000
Closed -$1.61M
MELI icon
44
Mercado Libre
MELI
$92B
-21,189
Closed -$6.21M
PM icon
45
Philip Morris
PM
$301B
-63,000
Closed -$4.21M
TEVA icon
46
Teva Pharmaceuticals
TEVA
$37.3B
-53,000
Closed -$817K
VIPS icon
47
Vipshop
VIPS
$6.96B
-52,644
Closed -$287K
XLRN
48
DELISTED
Acceleron Pharma
XLRN
-14,369
Closed -$626K
CELG
49
DELISTED
Celgene Corp
CELG
-107,491
Closed -$6.89M
FNSR
50
DELISTED
Finisar Corp
FNSR
-391,000
Closed -$8.45M

Similar funds

NF Trinity Capital's Q1 2019 Portfolio in Review

As of Q1 2019, NF Trinity Capital held 50 positions worth $626M, up 1.7% from $615M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

NF Trinity Capital withdrew a net $107M in Q1 2019, closing 11 positions and reducing 12 holdings. Its most notable exit was Finisar Corp, an estimated $8.45M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, NF Trinity Capital opened a new position in Booking.com worth $3.07M.

  • NF Trinity Capital's largest Q1 2019 buy was Booking.com: 44,000 shares worth $3.07M.
  • NF Trinity Capital added most to Walt Disney in Q1 2019, an estimated $5.16M increase.
  • NF Trinity Capital's biggest Q1 2019 reduction was Alibaba, cutting an estimated $14M.
  • NF Trinity Capital fully exited Finisar Corp in Q1 2019, selling an estimated $8.45M.
  • NF Trinity Capital's ten largest holdings make up 70% of its $626M portfolio in Q1 2019.
  • NF Trinity Capital opened 1 new position and closed 11 in Q1 2019.
  • NF Trinity Capital's portfolio value rose 1.7% quarter-over-quarter to $626M.

Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.